Nov 4, 2024 | Bureau of Securities | Cease and Desist | crypto token staking reward | crypto-related investments | Digital Assets | Division of Consumer Affairs | Full Refund of Assets | GS Partners | GSB | GSB Gold Standard Corporation AG | investor funds | Lydian World | Metaverse Technology | Multistate Securities Investigation | NJ Residents | physical gold | Securities | tokenized shares | unlawful sale of investment products | vouchers | Bureau of Securities | Consumer Protection | Division of Consumer Affairs | Press Release | Protecting New Jersey Consumers | Protecting New Jersey in Court
NJ Residents Entitled to Full Refund of Assets Invested in Securities Tied to Digital Assets and Metaverse Technology For Immediate Release: November 4, 2024 Office of the Attorney General- Matthew J. Platkin, Attorney GeneralDivision of Consumer Affairs- Cari...
Nov 1, 2024 | cardiologist | Conviction | Criminal Sexual Contact | defrauded insurance providers | Fazal Panezai | fourth-degree criminal sexual contact | fraudulent insurance reimbursements | health insurance benefit programs | Insurance Fraud Scheme | Matawan-Aberdeen Heart & Medical Center | Monmouth County Physician | New Jersey Office of the Insurance Fraud Prosecutor | OIFP | Revokes License | State Medical Board | submission of fraudulent claims | Consumer Protection | Division of Consumer Affairs | Division of Law | Press Release
Doctor Also Facing Unrelated Allegations of Criminal Sexual Contact Against Patient For Immediate Release: November 1, 2024 Office of the Attorney General- Matthew J. Platkin, Attorney GeneralDivision of Consumer Affairs- Cari Fais, DirectorDivision of Law- Michael...
Nov 1, 2024 | 25 individual executives | 30 corporate defendants | Agreements | antitrust laws | Apotex | artificially inflate and manipulate prices | Generic Drug Firms | generic prescription drugs | Hartford | health insurers | Heritage | Heritage Pharmaceuticals | Hospitals | Jason Malek | Jeffery Glazer | long-running conspiracies | Marketing | Multistate Coalition | multistate lawsuits | operations | patients | pricing | reduce competition | sales | Settlements | Teva Pharmaceuticals | United States District Court for the District of Connecticut | unreasonably restrain trade | widespread | Consumer Protection | Division of Consumer Affairs | Press Release | Protecting New Jersey Consumers | Protecting New Jersey in Court
Multistate Lawsuits Alleged Conspiracies to Inflate Drug Prices and Limit Competition For Immediate Release: November 1, 2024 Office of the Attorney General- Matthew J. Platkin, Attorney GeneralDivision of Consumer Affairs- Cari Fais, DirectorDivision of Law- Michael...
Oct 29, 2024 | "Redlining" | Asian communities | Black communities | DCR | Discrimination | Division on Civil Rights | FDIC | Federal Deposit Insurance Corporation | Hispanic communities | Investigation | natural origin | New Jersey Law Against Discrimination. | NJLAD | race | report | Republic First Bank | unlawful mortgage redlining | Addressing Hate, Bias & Discrimination | Bias and Discrimination | Consumer Protection | Division of Consumer Affairs | Division of Law | Press Release | Protecting New Jersey Consumers
Attorney General Matthew J. Platkin and the Division on Civil Rights (DCR) today issued a report outlining the findings of a multi-year investigation into allegations of unlawful mortgage redlining and discrimination by Republic First Bank.
Oct 28, 2024 | 51 professional and occupational boards | 60000 registered businesses | 750000 licensed professionals | Bureau of Securities | Cari Fais | Charities Section | Cybersecurity | data privacy | DCA | Division of Consumer Affairs | First Latina Director | Legalized Games of Chance | Office of Consumer Protection | Office of Weights and Measures | Regulated Business Section | Senate confirmation | technology accountability | Consumer Protection | Division of Consumer Affairs | Press Release | Protecting New Jersey Consumers | Protecting New Jersey in Court
Attorney General Matthew J. Platkin today announced the confirmation of Cari Fais as the Director of the Division of Consumer Affairs (“Division”).
Oct 16, 2024 | Adopted New Rules | DCA | Division of Consumer Affairs | Drug Affordability Council | drug supply chain | emerging trends in drug pricing | How and Why Prices Are Increased | insurance carriers | manufacturers | pharmacy benefits managers | pharmacy services administrative organizations | Prescription Drug Prices | Promoting Greater Transparency in Prescription Drug Pricing | regulatory policies | Wholesalers | Consumer Protection | Division of Consumer Affairs | Press Release | Proposed Rules | Protecting New Jersey in Court
Advancing the Murphy Administration’s efforts to rein in the high cost of prescription drugs in New Jersey, Attorney General Matthew J. Platkin and the Division of Consumer Affairs (“Division”) announced specially adopted new rules promoting greater transparency in prescription drug pricing.
